Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998

Journal of Antimicrobial Chemotherapy

Volumn 44, Issue 6, 1999, Pages 749-759

  Thornsberry, Clyde ^a   Jones, Mark E ^b   Hickey, Mary L ^b   Mauriz, Yolanda ^c   Kahn, James ^c   Sahm, Daniel F ^b  

^a MRL Pharmaceutical Services   (United States)

^b Ortho McNeil Pharmaceutical ^*

^c Ortho McNeil Pharmaceutical Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; BETA LACTAM; BETA LACTAMASE; CEFTRIAXONE; CEFUROXIME; CLARITHROMYCIN; COTRIMOXAZOLE; GLYCOPEPTIDE; LEVOFLOXACIN; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

AGE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; CONTROLLED STUDY; GEOGRAPHIC DISTRIBUTION; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NONHUMAN; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EID: 0032778571     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/44.6.749     Document Type: Article

References (26)

1. Kronenberger, C. B., Hoffman, R. E., Lezotte, D. C. & Marine, W. M. (1996). Invasive penicillin-resistant pneumococcal infections: a prevalence and historical cohort study. Emerging Infectious Diseases 2, 121-4.
2. Doern, G. V., Brueggemann, A., Holley, H. P. & Rauch, A. M. (1996). Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrobial Agents and Chemotherapy 40, 1208-13.
3. Jorgensen, J. H., Doern, G. V., Maher, L. A., Howell, A. W. & Redding, J. S. (1990). Antimicrobial resistance amongst respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrobial Agents and Chemotherapy 34, 2075-80.
4. Spika, J. S., Facklam, R. R., Plikaytis, B. D. & Oxtoby, M. J. (1991). Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. The Pneumococcal Surveillance Working Group. Journal of Infectious Diseases 163, 1273-8.
5. Thornsberry, C., Ogilvie, P., Kahn, J. & Mauriz, Y. (1997). Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group. Diagnostic Microbiology and Infectious Disease 29, 249-57.
6. Breiman, R. F., Butler, J. C., Tenover, F. C., Elliott, J. A. & Facklam, R. R. (1994). Emergence of drug-resistant pneumococcal infections in the United States. Journal of the American Medical Association 271, 1831-5.
7. Butler, J. C., Hofmann, J., Cetron, M. S., Elliott, J. A., Facklam, R. R. & Breiman, R. F. (1996). The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumo-coccal Sentinel Surveillance System. Journal of Infectious Diseases 174, 986-93.
8. Pfaller, M. A., Jones, R. N., Doern, G. V. & Kugler, K. (1998). Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program. Antimicrobial Agents and Chemotherapy 42, 1762-70.
9. Doern, G. V., Pfaller, M. A., Kugler, K., Freeman, J. & Jones, R. N. (1998). Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY Antimicrobial Surveillance Program. Clinical Infectious Diseases 27, 764-70.
10. Thornsberry, C., Ogilvie, P. T., Holley, H. P. & Sahm, D. F. (1998). In vitro activity of grepafloxacin and 25 other antimicrobial agents against Streptococcus pneumoniae: correlation with penicillin resistance. Clinical Therapeutics 20, 1179-90.
11. Bartlett, J. G. & Mundy, L. M. (1995). Community-acquired pneumonia. New England Journal of Medicine 333, 1618-24.
12. Harrison, P. F. and Lederberg, J., Eds. (1998). Antimicrobial Resistance: Issues and Options. Workshop Report. Institute of Medicine. National Academy Press, Washington, DC.
13. Doern, G. V., Jones, R. N., Pfaller, M. A., Kugler, K. & The Sentry Participants Group. (1999). Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrobial Agents and Chemotherapy 43, 385-9.
14. Hogan, P. A. & Sheehan, D. J. (1998). Macrolide susceptibility and β-lactamase production among Haemophilus influenzae isolates in the United States, 1996-1997. Antimicrobial Agents and Chemotherapy 42, 3313-4.
15. Baron, E. J. & Murray, P. R. (1995). Bacteriology. In Manual of Clinical Microbiology, 6th edn, (Murray, P. R., Baron, E. J., Pfaller, M. A., Tenover, F. C. & Yolken, R. H., Eds), pp. 246-662. American Society for Microbiology, Washington, DC.
16. National Committee for Clinical Laboratory Standards. (1998). Performance Standards for Antimicrobial Susceptibility Testing - Eighth Informational Supplement: Approved Standard M100-S8. NCCLS, Villanova, PA.
17. Jacobs, M. R., Koornhof, H. J., Robins-Browne, R. M., Stevenson, C. M., Vermaak, Z. A., Freiman, I. et al. (1978). Emergence of multiply resistant pneumococci. New England Journal of Medicine 299, 735-40.
18. Thornsberry, C., Brown, S. D., Yee, Y. C., Bouchillon, S. K., Marler, J. K. & Rich, T. (1993). Increasing penicillin resistance in Streptococcus pneumoniae in the US: effect on susceptibility to oral cephalosporins. Infections in Medicine 12, Suppl., S15-S24.
19. Ballow, C. H., Jones, R. N., Johnson, D. M., Deinhart, J. A. & Schentag, J. J. (1997). Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA. SPAR Study Group. Diagnostic Microbiology and Infectious Disease 29, 173-86.
20. Felmingham, D., Robbins, M. J., Ingley, K., Mathias, I., Bhogal, H., Leakey, A. et al. (1997). In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates. Journal of Antimicrobial Chemotherapy 39, Suppl. B, 43-9.
21. Hickey, M. L., Thornsberry, C., Diakun, D. R., Mani, S. V. & Sahm, D. F. Activity of ciprofloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis: Has it changed in the last decade? In Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 1998. Abstract E-20, p. 172. American Society for Microbiology, Washington, DC.
22. Thornsberry, C., Hickey, M. L, Diakun, D. R., Mani, S. V., Jones, M. E. & Sahm, D. F. (1999). International surveillance of susceptibility to levofloxacin and other agents among respiratory pathogens. Drugs 58, 364-5.
23. Plouffe, J. F. (1996). Levofloxacin in vitro activity against bacteremic isolates of Streptococcus pneumoniae. Franklin County Pneumonia Study Group. Diagnostic Microbiology and Infectious Disease 25, 43-5.
24. Goldsmith, C. E., Moore, J. E., Murphy, P. G. & Ambler, J. E. (1998). Increased incidence of ciprofloxacin resistance in penicillin-resistant pneumococci in Northern Ireland. Journal of Antimicrobial Chemotherapy 41, 420-1.
25. Doern, G. V., Brueggemann, A. B., Pierce, G., Holley, H. P. & Rauch, A. (1997). Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrobial Agents and Chemotherapy 41, 292-7.
26. Doern, G. V., Brueggemann, A. B., Pierce, G., Hogan, T., Holley, H. P. & Rauch, A. (1996). Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study. Antimicrobial Agents and Chemotherapy 40, 2884-6.